What is Dario?
Dario is at the forefront of revolutionizing personal health management by offering digital solutions designed for lasting behavior change. The company's platform integrates comprehensive support for a wide spectrum of health needs, from general well-being to the management of chronic conditions, aiming to empower members toward sustained health success. Leveraging a decade of direct-to-consumer experience, Dario utilizes billions of data insights to deliver highly personalized and adaptive member experiences. This data-driven approach ensures continuous evolution of its offerings to meet dynamic member requirements, resulting in high-impact clinical and financial outcomes for its clients.
How much funding has Dario raised?
Dario has raised a total of $113.6M across 4 funding rounds:
Share Placement
$28.6M
Debt
$50M
Stock/Share Issuance
$17.5M
Private Equity
$17.5M
Share Placement (2020): $28.6M with participation from Soleus Capital Management L.P., Psagot investment house, Phoenix insurance, Mor provident fund, Nantahala Capital Management, LLC, and Manchester Management Company LLC
Debt (2022): $50M led by OrbiMed
Stock/Share Issuance (2025): $17.5M, investors not publicly disclosed
Private Equity (2025): $17.5M, investors not publicly disclosed
Key Investors in Dario
OrbiMed
OrbiMed is a specialized investment firm with deep expertise in the healthcare sector, managing capital across biopharmaceuticals, medical devices, digital health platforms, diagnostics, and healthcare services. They support companies at various stages of development, from early-stage ventures to established organizations scaling proven healthcare solutions.
Soleus Capital Management L.P.
Soleus Capital Management L.P. is an investment firm that participated in Dario's funding round. Specific details regarding their investment focus or domain expertise are not provided in the available data.
Psagot investment house
Psagot Investment House is an entity that provided backing to Dario. Further information on their specific investment thesis or operational focus is not detailed in the provided context.
What's next for Dario?
The recent major strategic investment signals a pivotal phase for Dario, likely indicating a move towards scaling operations, expanding market reach, and further enhancing its data analytics capabilities. This substantial backing suggests Dario is poised for significant growth, potentially focusing on strategic partnerships and technological advancements to solidify its leadership in the digital health sector. The company's ability to demonstrate high-impact clinical and financial outcomes will be crucial as it navigates this expansion phase, aiming to capture a larger share of the enterprise health management market.
See full Dario company page
